Health Populi
APRIL 24, 2018
Biotech is roughly tied for second place with consumer health, dropping also by 7 points. There’s another piece of math worth doing here: a chasm between biotech and pharma of 17 percentage points worth of trust — that is the difference between the 55% of American trusting biotech versus 38% trusting pharma.
Lloyd Price
JULY 5, 2018
For many biotech companies, mergers and acquisitions have become a cornerstone in building a robust pipeline that can ensure positive growth for years to come. 2017 was considered to be a lean year for M&A in biotech. Although 2017 was slow for M&A activity, analysts have predicted 2018 could be a return to a spending frenzy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Insulin Nation
MAY 1, 2015
in 2015 or 2016, and it would be projected to generate $3 billion a year in global sales. According to a Fierce Biotech report on Tresiba, Novo’s resubmission of Tresiba could backfire for a couple of reasons, say analysts. Tresiba has already launched in Europe, Mexico and Japan.
Lloyd Price
JUNE 14, 2018
In September 2016, Google Acquired Apigee, the leading provider of FHIR based API’s effectively stealing a march on its competitors, however we are yet to see the application of Apigee's technology in connecting hospital EHRs with Android (mobile operating system developed by Google) using FHIR. link] [link]
Lloyd Price
JANUARY 10, 2019
Significantly exceeding 2017 in $ size, and doubling 2016, the Asia ecosystem is fast catching the US. HealthTech does not include Biotech, such as protein research or pharmaceuticals, and also does not include MedDev, such as devices that are implanted into the body. We recommend reviewing our taxonomy on slide 49 for further details.
Lloyd Price
SEPTEMBER 30, 2024
Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. link] Key Milestones and Investments: Early Years (2016-2018): NVentures made initial investments in startups focused on gaming, virtual reality, and self-driving cars. Paige.AI : A medical imaging company specialising in AI-powered diagnostics.
Insulin Nation
AUGUST 27, 2014
Now the drug manufacturer is happily announcing that its trials to clear up the concerns are going ahead of schedule, according to Fierce Biotech. Company officials now believe they will even be able get their insulin out to market in 2016 , which must mean they think the trials will show their insulin in a very favorable light.
Expert insights. Personalized for you.
185 
Let's personalize your content